AlzeCure Pharma (Sweden) Alpha and Beta Analysis

ALZCUR Stock  SEK 1.19  0.16  15.53%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AlzeCure Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in AlzeCure Pharma over a specified time horizon. Remember, high AlzeCure Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AlzeCure Pharma's market risk premium analysis include:
Beta
0.94
Alpha
(0.90)
Risk
4.25
Sharpe Ratio
(0.16)
Expected Return
(0.69)
Please note that although AlzeCure Pharma alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, AlzeCure Pharma did 0.90  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of AlzeCure Pharma stock's relative risk over its benchmark. AlzeCure Pharma has a beta of 0.94  . AlzeCure Pharma returns are very sensitive to returns on the market. As the market goes up or down, AlzeCure Pharma is expected to follow. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out AlzeCure Pharma Backtesting, AlzeCure Pharma Valuation, AlzeCure Pharma Correlation, AlzeCure Pharma Hype Analysis, AlzeCure Pharma Volatility, AlzeCure Pharma History and analyze AlzeCure Pharma Performance.

AlzeCure Pharma Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AlzeCure Pharma market risk premium is the additional return an investor will receive from holding AlzeCure Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AlzeCure Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AlzeCure Pharma's performance over market.
α-0.9   β0.94

AlzeCure Pharma expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AlzeCure Pharma's Buy-and-hold return. Our buy-and-hold chart shows how AlzeCure Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

AlzeCure Pharma Market Price Analysis

Market price analysis indicators help investors to evaluate how AlzeCure Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AlzeCure Pharma shares will generate the highest return on investment. By understating and applying AlzeCure Pharma stock market price indicators, traders can identify AlzeCure Pharma position entry and exit signals to maximize returns.

AlzeCure Pharma Return and Market Media

The median price of AlzeCure Pharma for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 1.81 with a coefficient of variation of 17.92. The daily time series for the period is distributed with a sample standard deviation of 0.31, arithmetic mean of 1.72, and mean deviation of 0.24. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About AlzeCure Pharma Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AlzeCure or other stocks. Alpha measures the amount that position in AlzeCure Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AlzeCure Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AlzeCure Pharma's short interest history, or implied volatility extrapolated from AlzeCure Pharma options trading.

Build Portfolio with AlzeCure Pharma

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in AlzeCure Stock

AlzeCure Pharma financial ratios help investors to determine whether AlzeCure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzeCure with respect to the benefits of owning AlzeCure Pharma security.